FDA approves Jazz’s Ziihera for HER2+ gastric cancer treatment

We haven't written up this one. Investing.com has the full story — the link below goes straight to it.

Also reported by 4 other outlets

U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma financialpost.com
FDA approves Jazz's Ziihera in frontline gastric cancer endpoints.news
Jazz wins FDA nod for cancer therapy developed with BeOne, Zymeworks seekingalpha.com
FDA approves Tevimbra combo for HER2+ gastric cancer treatment investing.com

More in Health & Medicine

Poor mental health in new parents predicts worse sleep months later

New parents expect to lose sleep, but a new longitudinal study reveals that early postpartum depression and anxiety can predict worse perceived sleep quality months later, creating a cycle of distress…

2h ago ·psypost.org

General : HRPB Hails Familyâs Selfless Organ Donation, Giving Hope To Transplant Patients

IPOH, Aug 25 (Bernama) -- In the midst of losing a loved one, a family in Ipoh made the difficult decision to donate his organs, giving hope to patients waiting for a chance at a new lease on life.

2h ago ·bernama.com

How much sleep do I need? Why you can forget the eight‑hour sleep rule

For decades, the answer to "how much sleep does an adult need?" has been simple: eight hours. The idea dates back to the mid-19th century, when the notion of eight hours of work, eight for recreation…

2h ago ·medicalxpress.com

More US employers to drop weight-loss drugs in 2027, as healthcare costs increase

14% of U.S. employers plan to stop using GLP-1 weight-loss drugs by 2027
Healthcare costs expected to rise 9.2% in 2027 from 8.5% in 2026
Pharmacy costs, accounting for a quarter of employers' healthcare spending, to increase 12% in 2027

1h ago ·investing.com

ARCH and Population Health join China blitz with Haisco deal

China-based drugmaker Haisco Pharmaceutical has been on a dealmaking tear this summer, and its latest alliance is with two dominant names in biotech.

1h ago ·endpoints.news

FDA Clears Blood Test to Detect Alzheimer's in Primary and Specialty Care

(MedPage Today) -- The FDA cleared the Elecsys pTau217 blood test to identify amyloid-beta pathology associated with Alzheimer's disease in people ages 55 and older with symptoms of cognitive decline…

1h ago ·medpagetoday.com